Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,686
Closed -$1.15M 86
2024
Q1
$1.15M Buy
+8,686
New +$1.07M 0.45% 41
2023
Q4
Sell
-7,581
Closed -$781K 83
2023
Q3
$781K Buy
7,581
+48
+0.6% +$5.17K 0.39% 51
2023
Q2
$869K Buy
7,533
+49
+0.7% +$5.56K 0.41% 51
2023
Q1
$796K Buy
7,484
+49
+0.7% +$5.29K 0.39% 56
2022
Q4
$825K Buy
7,435
+59
+0.8% +$6.03K 0.44% 55
2022
Q3
$635K Buy
7,376
+53
+0.7% +$4.73K 0.36% 63
2022
Q2
$668K Buy
7,323
+59
+0.8% +$5.23K 0.32% 69
2022
Q1
$596K Buy
7,264
+64
+0.9% +$5.05K 0.27% 79
2021
Q4
$551K Hold
7,200
0.23% 89
2021
Q3
$540K Sell
7,200
-132
-2% -$10K 0.24% 90
2021
Q2
$570K Sell
7,332
-214
-3% -$15.9K 0.25% 93
2021
Q1
$555K Buy
7,546
+210
+3% +$15.5K 0.28% 83
2020
Q4
$572K Buy
+7,336
New +$561K 0.32% 70

Other funds holding MRK

Oxler Private Wealth's MRK Position: Q2 2024 in Review

Oxler Private Wealth sold out of Merck (MRK) in Q2 2024, closing a stake of 8,686 shares — an estimated $1.15M sold.

Oxler Private Wealth first reported a position in MRK in Q4 2020 and held it in 13 quarters. The position peaked at $1.15M in Q1 2024. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Oxler Private Wealth reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Oxler Private Wealth sold 8,686 Merck shares in Q2 2024, an estimated $1.15M.
  • Oxler Private Wealth first reported a position in Merck in Q4 2020 and held it in 13 quarters.
  • Oxler Private Wealth's Merck position peaked at $1.15M in Q1 2024.
  • 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Oxler Private Wealth's 13F filing for Q2 2024, filed 30 Jul 2024.